Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Not Yet Recruiting NCT05696600

Impact of Supracrestal Tissue Attachment Dimension on Outcome of Scaling and Root Planing and Open Flap Debridement Procedure in Different Periodontal Phenotypes

Conditions: Periodontitis

Sex: All
Ages: 30 Years – 45 Years
Healthy volunteers: 1
Phase: NA
Enrollment: 48
Sponsor: Postgraduate Institute of Dental Sciences Rohtak

Location: India

Summary

The existence of supracrestal tissue attachment (SCTA) is fundamental for adhesion of the junctional epithelium and insertion of the connective fibers to the dental structure, besides functioning as a barrier against microbial entry in the periodontium. Wide variation in SCTA dimension have been reported in patients with and without periodontitis. If the physiologic dimension of SCTA is violated then it may lead to inflammation in periodontium. Influence of dimension of SCTA on scaling and root planning and open flap debridement procedure has not been investigated till date. Thus the aim of study is to assess the influence of SCTA dimension on the outcome of scaling and root planning followed by open flap debridement in patients with stage 2 and stage 3 periodontitis and also to estimate the SCTA dimension in thick versus thin periodontal phenotype.

Eligibility Criteria

Inclusion Criteria:Patients with generalised stage II or stage III periodontitisMaxillary or mandibular incisors having same periodontal phenotypeExclusion Criteria:- 1. Patient with systemic diseases like uncontrolled diabetes, hypertension, bleeding disorders, coronary artery disease etc.2. Malaligned teeth 3. Patient having undergone any periodontal therapy within one year 4. Pregnant and lactating females 5. Patient on antibiotic therapy in the past one month

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05696600). StuddyBuddy aggregates publicly available trial information.